- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
According to our latest study, the global Precision Cancer Therapeutics market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Precision Cancer Therapeutics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Precision Cancer Therapeutics market size and forecasts, in consumption value ($ Million), 2018-2029
Global Precision Cancer Therapeutics market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Precision Cancer Therapeutics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Precision Cancer Therapeutics market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Precision Cancer Therapeutics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Precision Cancer Therapeutics market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie, Astellas Pharma U.S., Inc, AstraZeneca PLC, Bayer AG and Bristol-Myers Squibb Company, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Precision Cancer Therapeutics market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Monoclonal Antibodies
Kinase Inhibitors
Angiogenesis Inhibitors
Proteasome Inhibitors
CAR-T Therapies
Other Precision Therapies
Market segment by Application
Breast Cancer
Lung Cancer
Prostate Cancer
Colon and Rectal Cancer
Others
Market segment by players, this report covers
AbbVie
Astellas Pharma U.S., Inc
AstraZeneca PLC
Bayer AG
Bristol-Myers Squibb Company
Clovis Oncology, Inc.
Dendreon Pharmaceuticals LLC
Eli Lilly & Company
EMD Serono, Inc. (Merck KgaA)
Eisai Co., Ltd.
Exelixis, Inc.
Gilead Sciences, Inc.
GlaxoSmithKline
Johnson & Johnson
Merck & Co., Inc.
Novartis AG
Otsuka Holdings Co., Ltd.
Pfizer, Inc.
Puma Biotechnology, Inc.
Roche (F. Hoffman-La Roche, Ltd.)
Sanofi/Genzyme
Seagen Inc.
Takeda
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Precision Cancer Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Precision Cancer Therapeutics, with revenue, gross margin and global market share of Precision Cancer Therapeutics from 2018 to 2023.
Chapter 3, the Precision Cancer Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Precision Cancer Therapeutics market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Precision Cancer Therapeutics.
Chapter 13, to describe Precision Cancer Therapeutics research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Precision Cancer Therapeutics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Precision Cancer Therapeutics by Type
1.3.1 Overview: Global Precision Cancer Therapeutics Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Precision Cancer Therapeutics Consumption Value Market Share by Type in 2022
1.3.3 Monoclonal Antibodies
1.3.4 Kinase Inhibitors
1.3.5 Angiogenesis Inhibitors
1.3.6 Proteasome Inhibitors
1.3.7 CAR-T Therapies
1.3.8 Other Precision Therapies
1.4 Global Precision Cancer Therapeutics Market by Application
1.4.1 Overview: Global Precision Cancer Therapeutics Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Breast Cancer
1.4.3 Lung Cancer
1.4.4 Prostate Cancer
1.4.5 Colon and Rectal Cancer
1.4.6 Others
1.5 Global Precision Cancer Therapeutics Market Size & Forecast
1.6 Global Precision Cancer Therapeutics Market Size and Forecast by Region
1.6.1 Global Precision Cancer Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Precision Cancer Therapeutics Market Size by Region, (2018-2029)
1.6.3 North America Precision Cancer Therapeutics Market Size and Prospect (2018-2029)
1.6.4 Europe Precision Cancer Therapeutics Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Precision Cancer Therapeutics Market Size and Prospect (2018-2029)
1.6.6 South America Precision Cancer Therapeutics Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Precision Cancer Therapeutics Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business
2.1.3 AbbVie Precision Cancer Therapeutics Product and Solutions
2.1.4 AbbVie Precision Cancer Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 AbbVie Recent Developments and Future Plans
2.2 Astellas Pharma U.S., Inc
2.2.1 Astellas Pharma U.S., Inc Details
2.2.2 Astellas Pharma U.S., Inc Major Business
2.2.3 Astellas Pharma U.S., Inc Precision Cancer Therapeutics Product and Solutions
2.2.4 Astellas Pharma U.S., Inc Precision Cancer Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Astellas Pharma U.S., Inc Recent Developments and Future Plans
2.3 AstraZeneca PLC
2.3.1 AstraZeneca PLC Details
2.3.2 AstraZeneca PLC Major Business
2.3.3 AstraZeneca PLC Precision Cancer Therapeutics Product and Solutions
2.3.4 AstraZeneca PLC Precision Cancer Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 AstraZeneca PLC Recent Developments and Future Plans
2.4 Bayer AG
2.4.1 Bayer AG Details
2.4.2 Bayer AG Major Business
2.4.3 Bayer AG Precision Cancer Therapeutics Product and Solutions
2.4.4 Bayer AG Precision Cancer Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Bayer AG Recent Developments and Future Plans
2.5 Bristol-Myers Squibb Company
2.5.1 Bristol-Myers Squibb Company Details
2.5.2 Bristol-Myers Squibb Company Major Business
2.5.3 Bristol-Myers Squibb Company Precision Cancer Therapeutics Product and Solutions
2.5.4 Bristol-Myers Squibb Company Precision Cancer Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Bristol-Myers Squibb Company Recent Developments and Future Plans
2.6 Clovis Oncology, Inc.
2.6.1 Clovis Oncology, Inc. Details
2.6.2 Clovis Oncology, Inc. Major Business
2.6.3 Clovis Oncology, Inc. Precision Cancer Therapeutics Product and Solutions
2.6.4 Clovis Oncology, Inc. Precision Cancer Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Clovis Oncology, Inc. Recent Developments and Future Plans
2.7 Dendreon Pharmaceuticals LLC
2.7.1 Dendreon Pharmaceuticals LLC Details
2.7.2 Dendreon Pharmaceuticals LLC Major Business
2.7.3 Dendreon Pharmaceuticals LLC Precision Cancer Therapeutics Product and Solutions
2.7.4 Dendreon Pharmaceuticals LLC Precision Cancer Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Dendreon Pharmaceuticals LLC Recent Developments and Future Plans
2.8 Eli Lilly & Company
2.8.1 Eli Lilly & Company Details
2.8.2 Eli Lilly & Company Major Business
2.8.3 Eli Lilly & Company Precision Cancer Therapeutics Product and Solutions
2.8.4 Eli Lilly & Company Precision Cancer Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Eli Lilly & Company Recent Developments and Future Plans
2.9 EMD Serono, Inc. (Merck KgaA)
2.9.1 EMD Serono, Inc. (Merck KgaA) Details
2.9.2 EMD Serono, Inc. (Merck KgaA) Major Business
2.9.3 EMD Serono, Inc. (Merck KgaA) Precision Cancer Therapeutics Product and Solutions
2.9.4 EMD Serono, Inc. (Merck KgaA) Precision Cancer Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 EMD Serono, Inc. (Merck KgaA) Recent Developments and Future Plans
2.10 Eisai Co., Ltd.
2.10.1 Eisai Co., Ltd. Details
2.10.2 Eisai Co., Ltd. Major Business
2.10.3 Eisai Co., Ltd. Precision Cancer Therapeutics Product and Solutions
2.10.4 Eisai Co., Ltd. Precision Cancer Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Eisai Co., Ltd. Recent Developments and Future Plans
2.11 Exelixis, Inc.
2.11.1 Exelixis, Inc. Details
2.11.2 Exelixis, Inc. Major Business
2.11.3 Exelixis, Inc. Precision Cancer Therapeutics Product and Solutions
2.11.4 Exelixis, Inc. Precision Cancer Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Exelixis, Inc. Recent Developments and Future Plans
2.12 Gilead Sciences, Inc.
2.12.1 Gilead Sciences, Inc. Details
2.12.2 Gilead Sciences, Inc. Major Business
2.12.3 Gilead Sciences, Inc. Precision Cancer Therapeutics Product and Solutions
2.12.4 Gilead Sciences, Inc. Precision Cancer Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Gilead Sciences, Inc. Recent Developments and Future Plans
2.13 GlaxoSmithKline
2.13.1 GlaxoSmithKline Details
2.13.2 GlaxoSmithKline Major Business
2.13.3 GlaxoSmithKline Precision Cancer Therapeutics Product and Solutions
2.13.4 GlaxoSmithKline Precision Cancer Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 GlaxoSmithKline Recent Developments and Future Plans
2.14 Johnson & Johnson
2.14.1 Johnson & Johnson Details
2.14.2 Johnson & Johnson Major Business
2.14.3 Johnson & Johnson Precision Cancer Therapeutics Product and Solutions
2.14.4 Johnson & Johnson Precision Cancer Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Johnson & Johnson Recent Developments and Future Plans
2.15 Merck & Co., Inc.
2.15.1 Merck & Co., Inc. Details
2.15.2 Merck & Co., Inc. Major Business
2.15.3 Merck & Co., Inc. Precision Cancer Therapeutics Product and Solutions
2.15.4 Merck & Co., Inc. Precision Cancer Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Merck & Co., Inc. Recent Developments and Future Plans
2.16 Novartis AG
2.16.1 Novartis AG Details
2.16.2 Novartis AG Major Business
2.16.3 Novartis AG Precision Cancer Therapeutics Product and Solutions
2.16.4 Novartis AG Precision Cancer Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Novartis AG Recent Developments and Future Plans
2.17 Otsuka Holdings Co., Ltd.
2.17.1 Otsuka Holdings Co., Ltd. Details
2.17.2 Otsuka Holdings Co., Ltd. Major Business
2.17.3 Otsuka Holdings Co., Ltd. Precision Cancer Therapeutics Product and Solutions
2.17.4 Otsuka Holdings Co., Ltd. Precision Cancer Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Otsuka Holdings Co., Ltd. Recent Developments and Future Plans
2.18 Pfizer, Inc.
2.18.1 Pfizer, Inc. Details
2.18.2 Pfizer, Inc. Major Business
2.18.3 Pfizer, Inc. Precision Cancer Therapeutics Product and Solutions
2.18.4 Pfizer, Inc. Precision Cancer Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Pfizer, Inc. Recent Developments and Future Plans
2.19 Puma Biotechnology, Inc.
2.19.1 Puma Biotechnology, Inc. Details
2.19.2 Puma Biotechnology, Inc. Major Business
2.19.3 Puma Biotechnology, Inc. Precision Cancer Therapeutics Product and Solutions
2.19.4 Puma Biotechnology, Inc. Precision Cancer Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Puma Biotechnology, Inc. Recent Developments and Future Plans
2.20 Roche (F. Hoffman-La Roche, Ltd.)
2.20.1 Roche (F. Hoffman-La Roche, Ltd.) Details
2.20.2 Roche (F. Hoffman-La Roche, Ltd.) Major Business
2.20.3 Roche (F. Hoffman-La Roche, Ltd.) Precision Cancer Therapeutics Product and Solutions
2.20.4 Roche (F. Hoffman-La Roche, Ltd.) Precision Cancer Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 Roche (F. Hoffman-La Roche, Ltd.) Recent Developments and Future Plans
2.21 Sanofi/Genzyme
2.21.1 Sanofi/Genzyme Details
2.21.2 Sanofi/Genzyme Major Business
2.21.3 Sanofi/Genzyme Precision Cancer Therapeutics Product and Solutions
2.21.4 Sanofi/Genzyme Precision Cancer Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 Sanofi/Genzyme Recent Developments and Future Plans
2.22 Seagen Inc.
2.22.1 Seagen Inc. Details
2.22.2 Seagen Inc. Major Business
2.22.3 Seagen Inc. Precision Cancer Therapeutics Product and Solutions
2.22.4 Seagen Inc. Precision Cancer Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.22.5 Seagen Inc. Recent Developments and Future Plans
2.23 Takeda
2.23.1 Takeda Details
2.23.2 Takeda Major Business
2.23.3 Takeda Precision Cancer Therapeutics Product and Solutions
2.23.4 Takeda Precision Cancer Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.23.5 Takeda Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Precision Cancer Therapeutics Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Precision Cancer Therapeutics by Company Revenue
3.2.2 Top 3 Precision Cancer Therapeutics Players Market Share in 2022
3.2.3 Top 6 Precision Cancer Therapeutics Players Market Share in 2022
3.3 Precision Cancer Therapeutics Market: Overall Company Footprint Analysis
3.3.1 Precision Cancer Therapeutics Market: Region Footprint
3.3.2 Precision Cancer Therapeutics Market: Company Product Type Footprint
3.3.3 Precision Cancer Therapeutics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Precision Cancer Therapeutics Consumption Value and Market Share by Type (2018-2023)
4.2 Global Precision Cancer Therapeutics Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Precision Cancer Therapeutics Consumption Value Market Share by Application (2018-2023)
5.2 Global Precision Cancer Therapeutics Market Forecast by Application (2024-2029)
6 North America
6.1 North America Precision Cancer Therapeutics Consumption Value by Type (2018-2029)
6.2 North America Precision Cancer Therapeutics Consumption Value by Application (2018-2029)
6.3 North America Precision Cancer Therapeutics Market Size by Country
6.3.1 North America Precision Cancer Therapeutics Consumption Value by Country (2018-2029)
6.3.2 United States Precision Cancer Therapeutics Market Size and Forecast (2018-2029)
6.3.3 Canada Precision Cancer Therapeutics Market Size and Forecast (2018-2029)
6.3.4 Mexico Precision Cancer Therapeutics Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Precision Cancer Therapeutics Consumption Value by Type (2018-2029)
7.2 Europe Precision Cancer Therapeutics Consumption Value by Application (2018-2029)
7.3 Europe Precision Cancer Therapeutics Market Size by Country
7.3.1 Europe Precision Cancer Therapeutics Consumption Value by Country (2018-2029)
7.3.2 Germany Precision Cancer Therapeutics Market Size and Forecast (2018-2029)
7.3.3 France Precision Cancer Therapeutics Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Precision Cancer Therapeutics Market Size and Forecast (2018-2029)
7.3.5 Russia Precision Cancer Therapeutics Market Size and Forecast (2018-2029)
7.3.6 Italy Precision Cancer Therapeutics Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Precision Cancer Therapeutics Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Precision Cancer Therapeutics Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Precision Cancer Therapeutics Market Size by Region
8.3.1 Asia-Pacific Precision Cancer Therapeutics Consumption Value by Region (2018-2029)
8.3.2 China Precision Cancer Therapeutics Market Size and Forecast (2018-2029)
8.3.3 Japan Precision Cancer Therapeutics Market Size and Forecast (2018-2029)
8.3.4 South Korea Precision Cancer Therapeutics Market Size and Forecast (2018-2029)
8.3.5 India Precision Cancer Therapeutics Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Precision Cancer Therapeutics Market Size and Forecast (2018-2029)
8.3.7 Australia Precision Cancer Therapeutics Market Size and Forecast (2018-2029)
9 South America
9.1 South America Precision Cancer Therapeutics Consumption Value by Type (2018-2029)
9.2 South America Precision Cancer Therapeutics Consumption Value by Application (2018-2029)
9.3 South America Precision Cancer Therapeutics Market Size by Country
9.3.1 South America Precision Cancer Therapeutics Consumption Value by Country (2018-2029)
9.3.2 Brazil Precision Cancer Therapeutics Market Size and Forecast (2018-2029)
9.3.3 Argentina Precision Cancer Therapeutics Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Precision Cancer Therapeutics Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Precision Cancer Therapeutics Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Precision Cancer Therapeutics Market Size by Country
10.3.1 Middle East & Africa Precision Cancer Therapeutics Consumption Value by Country (2018-2029)
10.3.2 Turkey Precision Cancer Therapeutics Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Precision Cancer Therapeutics Market Size and Forecast (2018-2029)
10.3.4 UAE Precision Cancer Therapeutics Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Precision Cancer Therapeutics Market Drivers
11.2 Precision Cancer Therapeutics Market Restraints
11.3 Precision Cancer Therapeutics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Precision Cancer Therapeutics Industry Chain
12.2 Precision Cancer Therapeutics Upstream Analysis
12.3 Precision Cancer Therapeutics Midstream Analysis
12.4 Precision Cancer Therapeutics Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Precision Cancer Therapeutics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Precision Cancer Therapeutics Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Precision Cancer Therapeutics Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Precision Cancer Therapeutics Consumption Value by Region (2024-2029) & (USD Million)
Table 5. AbbVie Company Information, Head Office, and Major Competitors
Table 6. AbbVie Major Business
Table 7. AbbVie Precision Cancer Therapeutics Product and Solutions
Table 8. AbbVie Precision Cancer Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. AbbVie Recent Developments and Future Plans
Table 10. Astellas Pharma U.S., Inc Company Information, Head Office, and Major Competitors
Table 11. Astellas Pharma U.S., Inc Major Business
Table 12. Astellas Pharma U.S., Inc Precision Cancer Therapeutics Product and Solutions
Table 13. Astellas Pharma U.S., Inc Precision Cancer Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Astellas Pharma U.S., Inc Recent Developments and Future Plans
Table 15. AstraZeneca PLC Company Information, Head Office, and Major Competitors
Table 16. AstraZeneca PLC Major Business
Table 17. AstraZeneca PLC Precision Cancer Therapeutics Product and Solutions
Table 18. AstraZeneca PLC Precision Cancer Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. AstraZeneca PLC Recent Developments and Future Plans
Table 20. Bayer AG Company Information, Head Office, and Major Competitors
Table 21. Bayer AG Major Business
Table 22. Bayer AG Precision Cancer Therapeutics Product and Solutions
Table 23. Bayer AG Precision Cancer Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Bayer AG Recent Developments and Future Plans
Table 25. Bristol-Myers Squibb Company Company Information, Head Office, and Major Competitors
Table 26. Bristol-Myers Squibb Company Major Business
Table 27. Bristol-Myers Squibb Company Precision Cancer Therapeutics Product and Solutions
Table 28. Bristol-Myers Squibb Company Precision Cancer Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Bristol-Myers Squibb Company Recent Developments and Future Plans
Table 30. Clovis Oncology, Inc. Company Information, Head Office, and Major Competitors
Table 31. Clovis Oncology, Inc. Major Business
Table 32. Clovis Oncology, Inc. Precision Cancer Therapeutics Product and Solutions
Table 33. Clovis Oncology, Inc. Precision Cancer Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Clovis Oncology, Inc. Recent Developments and Future Plans
Table 35. Dendreon Pharmaceuticals LLC Company Information, Head Office, and Major Competitors
Table 36. Dendreon Pharmaceuticals LLC Major Business
Table 37. Dendreon Pharmaceuticals LLC Precision Cancer Therapeutics Product and Solutions
Table 38. Dendreon Pharmaceuticals LLC Precision Cancer Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Dendreon Pharmaceuticals LLC Recent Developments and Future Plans
Table 40. Eli Lilly & Company Company Information, Head Office, and Major Competitors
Table 41. Eli Lilly & Company Major Business
Table 42. Eli Lilly & Company Precision Cancer Therapeutics Product and Solutions
Table 43. Eli Lilly & Company Precision Cancer Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Eli Lilly & Company Recent Developments and Future Plans
Table 45. EMD Serono, Inc. (Merck KgaA) Company Information, Head Office, and Major Competitors
Table 46. EMD Serono, Inc. (Merck KgaA) Major Business
Table 47. EMD Serono, Inc. (Merck KgaA) Precision Cancer Therapeutics Product and Solutions
Table 48. EMD Serono, Inc. (Merck KgaA) Precision Cancer Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. EMD Serono, Inc. (Merck KgaA) Recent Developments and Future Plans
Table 50. Eisai Co., Ltd. Company Information, Head Office, and Major Competitors
Table 51. Eisai Co., Ltd. Major Business
Table 52. Eisai Co., Ltd. Precision Cancer Therapeutics Product and Solutions
Table 53. Eisai Co., Ltd. Precision Cancer Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Eisai Co., Ltd. Recent Developments and Future Plans
Table 55. Exelixis, Inc. Company Information, Head Office, and Major Competitors
Table 56. Exelixis, Inc. Major Business
Table 57. Exelixis, Inc. Precision Cancer Therapeutics Product and Solutions
Table 58. Exelixis, Inc. Precision Cancer Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Exelixis, Inc. Recent Developments and Future Plans
Table 60. Gilead Sciences, Inc. Company Information, Head Office, and Major Competitors
Table 61. Gilead Sciences, Inc. Major Business
Table 62. Gilead Sciences, Inc. Precision Cancer Therapeutics Product and Solutions
Table 63. Gilead Sciences, Inc. Precision Cancer Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Gilead Sciences, Inc. Recent Developments and Future Plans
Table 65. GlaxoSmithKline Company Information, Head Office, and Major Competitors
Table 66. GlaxoSmithKline Major Business
Table 67. GlaxoSmithKline Precision Cancer Therapeutics Product and Solutions
Table 68. GlaxoSmithKline Precision Cancer Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. GlaxoSmithKline Recent Developments and Future Plans
Table 70. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 71. Johnson & Johnson Major Business
Table 72. Johnson & Johnson Precision Cancer Therapeutics Product and Solutions
Table 73. Johnson & Johnson Precision Cancer Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Johnson & Johnson Recent Developments and Future Plans
Table 75. Merck & Co., Inc. Company Information, Head Office, and Major Competitors
Table 76. Merck & Co., Inc. Major Business
Table 77. Merck & Co., Inc. Precision Cancer Therapeutics Product and Solutions
Table 78. Merck & Co., Inc. Precision Cancer Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Merck & Co., Inc. Recent Developments and Future Plans
Table 80. Novartis AG Company Information, Head Office, and Major Competitors
Table 81. Novartis AG Major Business
Table 82. Novartis AG Precision Cancer Therapeutics Product and Solutions
Table 83. Novartis AG Precision Cancer Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Novartis AG Recent Developments and Future Plans
Table 85. Otsuka Holdings Co., Ltd. Company Information, Head Office, and Major Competitors
Table 86. Otsuka Holdings Co., Ltd. Major Business
Table 87. Otsuka Holdings Co., Ltd. Precision Cancer Therapeutics Product and Solutions
Table 88. Otsuka Holdings Co., Ltd. Precision Cancer Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Otsuka Holdings Co., Ltd. Recent Developments and Future Plans
Table 90. Pfizer, Inc. Company Information, Head Office, and Major Competitors
Table 91. Pfizer, Inc. Major Business
Table 92. Pfizer, Inc. Precision Cancer Therapeutics Product and Solutions
Table 93. Pfizer, Inc. Precision Cancer Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Pfizer, Inc. Recent Developments and Future Plans
Table 95. Puma Biotechnology, Inc. Company Information, Head Office, and Major Competitors
Table 96. Puma Biotechnology, Inc. Major Business
Table 97. Puma Biotechnology, Inc. Precision Cancer Therapeutics Product and Solutions
Table 98. Puma Biotechnology, Inc. Precision Cancer Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. Puma Biotechnology, Inc. Recent Developments and Future Plans
Table 100. Roche (F. Hoffman-La Roche, Ltd.) Company Information, Head Office, and Major Competitors
Table 101. Roche (F. Hoffman-La Roche, Ltd.) Major Business
Table 102. Roche (F. Hoffman-La Roche, Ltd.) Precision Cancer Therapeutics Product and Solutions
Table 103. Roche (F. Hoffman-La Roche, Ltd.) Precision Cancer Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 104. Roche (F. Hoffman-La Roche, Ltd.) Recent Developments and Future Plans
Table 105. Sanofi/Genzyme Company Information, Head Office, and Major Competitors
Table 106. Sanofi/Genzyme Major Business
Table 107. Sanofi/Genzyme Precision Cancer Therapeutics Product and Solutions
Table 108. Sanofi/Genzyme Precision Cancer Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 109. Sanofi/Genzyme Recent Developments and Future Plans
Table 110. Seagen Inc. Company Information, Head Office, and Major Competitors
Table 111. Seagen Inc. Major Business
Table 112. Seagen Inc. Precision Cancer Therapeutics Product and Solutions
Table 113. Seagen Inc. Precision Cancer Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 114. Seagen Inc. Recent Developments and Future Plans
Table 115. Takeda Company Information, Head Office, and Major Competitors
Table 116. Takeda Major Business
Table 117. Takeda Precision Cancer Therapeutics Product and Solutions
Table 118. Takeda Precision Cancer Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Takeda Recent Developments and Future Plans
Table 120. Global Precision Cancer Therapeutics Revenue (USD Million) by Players (2018-2023)
Table 121. Global Precision Cancer Therapeutics Revenue Share by Players (2018-2023)
Table 122. Breakdown of Precision Cancer Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 123. Market Position of Players in Precision Cancer Therapeutics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 124. Head Office of Key Precision Cancer Therapeutics Players
Table 125. Precision Cancer Therapeutics Market: Company Product Type Footprint
Table 126. Precision Cancer Therapeutics Market: Company Product Application Footprint
Table 127. Precision Cancer Therapeutics New Market Entrants and Barriers to Market Entry
Table 128. Precision Cancer Therapeutics Mergers, Acquisition, Agreements, and Collaborations
Table 129. Global Precision Cancer Therapeutics Consumption Value (USD Million) by Type (2018-2023)
Table 130. Global Precision Cancer Therapeutics Consumption Value Share by Type (2018-2023)
Table 131. Global Precision Cancer Therapeutics Consumption Value Forecast by Type (2024-2029)
Table 132. Global Precision Cancer Therapeutics Consumption Value by Application (2018-2023)
Table 133. Global Precision Cancer Therapeutics Consumption Value Forecast by Application (2024-2029)
Table 134. North America Precision Cancer Therapeutics Consumption Value by Type (2018-2023) & (USD Million)
Table 135. North America Precision Cancer Therapeutics Consumption Value by Type (2024-2029) & (USD Million)
Table 136. North America Precision Cancer Therapeutics Consumption Value by Application (2018-2023) & (USD Million)
Table 137. North America Precision Cancer Therapeutics Consumption Value by Application (2024-2029) & (USD Million)
Table 138. North America Precision Cancer Therapeutics Consumption Value by Country (2018-2023) & (USD Million)
Table 139. North America Precision Cancer Therapeutics Consumption Value by Country (2024-2029) & (USD Million)
Table 140. Europe Precision Cancer Therapeutics Consumption Value by Type (2018-2023) & (USD Million)
Table 141. Europe Precision Cancer Therapeutics Consumption Value by Type (2024-2029) & (USD Million)
Table 142. Europe Precision Cancer Therapeutics Consumption Value by Application (2018-2023) & (USD Million)
Table 143. Europe Precision Cancer Therapeutics Consumption Value by Application (2024-2029) & (USD Million)
Table 144. Europe Precision Cancer Therapeutics Consumption Value by Country (2018-2023) & (USD Million)
Table 145. Europe Precision Cancer Therapeutics Consumption Value by Country (2024-2029) & (USD Million)
Table 146. Asia-Pacific Precision Cancer Therapeutics Consumption Value by Type (2018-2023) & (USD Million)
Table 147. Asia-Pacific Precision Cancer Therapeutics Consumption Value by Type (2024-2029) & (USD Million)
Table 148. Asia-Pacific Precision Cancer Therapeutics Consumption Value by Application (2018-2023) & (USD Million)
Table 149. Asia-Pacific Precision Cancer Therapeutics Consumption Value by Application (2024-2029) & (USD Million)
Table 150. Asia-Pacific Precision Cancer Therapeutics Consumption Value by Region (2018-2023) & (USD Million)
Table 151. Asia-Pacific Precision Cancer Therapeutics Consumption Value by Region (2024-2029) & (USD Million)
Table 152. South America Precision Cancer Therapeutics Consumption Value by Type (2018-2023) & (USD Million)
Table 153. South America Precision Cancer Therapeutics Consumption Value by Type (2024-2029) & (USD Million)
Table 154. South America Precision Cancer Therapeutics Consumption Value by Application (2018-2023) & (USD Million)
Table 155. South America Precision Cancer Therapeutics Consumption Value by Application (2024-2029) & (USD Million)
Table 156. South America Precision Cancer Therapeutics Consumption Value by Country (2018-2023) & (USD Million)
Table 157. South America Precision Cancer Therapeutics Consumption Value by Country (2024-2029) & (USD Million)
Table 158. Middle East & Africa Precision Cancer Therapeutics Consumption Value by Type (2018-2023) & (USD Million)
Table 159. Middle East & Africa Precision Cancer Therapeutics Consumption Value by Type (2024-2029) & (USD Million)
Table 160. Middle East & Africa Precision Cancer Therapeutics Consumption Value by Application (2018-2023) & (USD Million)
Table 161. Middle East & Africa Precision Cancer Therapeutics Consumption Value by Application (2024-2029) & (USD Million)
Table 162. Middle East & Africa Precision Cancer Therapeutics Consumption Value by Country (2018-2023) & (USD Million)
Table 163. Middle East & Africa Precision Cancer Therapeutics Consumption Value by Country (2024-2029) & (USD Million)
Table 164. Precision Cancer Therapeutics Raw Material
Table 165. Key Suppliers of Precision Cancer Therapeutics Raw Materials
List of Figures
Figure 1. Precision Cancer Therapeutics Picture
Figure 2. Global Precision Cancer Therapeutics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Precision Cancer Therapeutics Consumption Value Market Share by Type in 2022
Figure 4. Monoclonal Antibodies
Figure 5. Kinase Inhibitors
Figure 6. Angiogenesis Inhibitors
Figure 7. Proteasome Inhibitors
Figure 8. CAR-T Therapies
Figure 9. Other Precision Therapies
Figure 10. Global Precision Cancer Therapeutics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 11. Precision Cancer Therapeutics Consumption Value Market Share by Application in 2022
Figure 12. Breast Cancer Picture
Figure 13. Lung Cancer Picture
Figure 14. Prostate Cancer Picture
Figure 15. Colon and Rectal Cancer Picture
Figure 16. Others Picture
Figure 17. Global Precision Cancer Therapeutics Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 18. Global Precision Cancer Therapeutics Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 19. Global Market Precision Cancer Therapeutics Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 20. Global Precision Cancer Therapeutics Consumption Value Market Share by Region (2018-2029)
Figure 21. Global Precision Cancer Therapeutics Consumption Value Market Share by Region in 2022
Figure 22. North America Precision Cancer Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Precision Cancer Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Precision Cancer Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Precision Cancer Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East and Africa Precision Cancer Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Precision Cancer Therapeutics Revenue Share by Players in 2022
Figure 28. Precision Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 29. Global Top 3 Players Precision Cancer Therapeutics Market Share in 2022
Figure 30. Global Top 6 Players Precision Cancer Therapeutics Market Share in 2022
Figure 31. Global Precision Cancer Therapeutics Consumption Value Share by Type (2018-2023)
Figure 32. Global Precision Cancer Therapeutics Market Share Forecast by Type (2024-2029)
Figure 33. Global Precision Cancer Therapeutics Consumption Value Share by Application (2018-2023)
Figure 34. Global Precision Cancer Therapeutics Market Share Forecast by Application (2024-2029)
Figure 35. North America Precision Cancer Therapeutics Consumption Value Market Share by Type (2018-2029)
Figure 36. North America Precision Cancer Therapeutics Consumption Value Market Share by Application (2018-2029)
Figure 37. North America Precision Cancer Therapeutics Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Precision Cancer Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 39. Canada Precision Cancer Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 40. Mexico Precision Cancer Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 41. Europe Precision Cancer Therapeutics Consumption Value Market Share by Type (2018-2029)
Figure 42. Europe Precision Cancer Therapeutics Consumption Value Market Share by Application (2018-2029)
Figure 43. Europe Precision Cancer Therapeutics Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Precision Cancer Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 45. France Precision Cancer Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 46. United Kingdom Precision Cancer Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 47. Russia Precision Cancer Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 48. Italy Precision Cancer Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Precision Cancer Therapeutics Consumption Value Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Precision Cancer Therapeutics Consumption Value Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Precision Cancer Therapeutics Consumption Value Market Share by Region (2018-2029)
Figure 52. China Precision Cancer Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 53. Japan Precision Cancer Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 54. South Korea Precision Cancer Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 55. India Precision Cancer Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 56. Southeast Asia Precision Cancer Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 57. Australia Precision Cancer Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 58. South America Precision Cancer Therapeutics Consumption Value Market Share by Type (2018-2029)
Figure 59. South America Precision Cancer Therapeutics Consumption Value Market Share by Application (2018-2029)
Figure 60. South America Precision Cancer Therapeutics Consumption Value Market Share by Country (2018-2029)
Figure 61. Brazil Precision Cancer Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 62. Argentina Precision Cancer Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 63. Middle East and Africa Precision Cancer Therapeutics Consumption Value Market Share by Type (2018-2029)
Figure 64. Middle East and Africa Precision Cancer Therapeutics Consumption Value Market Share by Application (2018-2029)
Figure 65. Middle East and Africa Precision Cancer Therapeutics Consumption Value Market Share by Country (2018-2029)
Figure 66. Turkey Precision Cancer Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 67. Saudi Arabia Precision Cancer Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 68. UAE Precision Cancer Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 69. Precision Cancer Therapeutics Market Drivers
Figure 70. Precision Cancer Therapeutics Market Restraints
Figure 71. Precision Cancer Therapeutics Market Trends
Figure 72. Porters Five Forces Analysis
Figure 73. Manufacturing Cost Structure Analysis of Precision Cancer Therapeutics in 2022
Figure 74. Manufacturing Process Analysis of Precision Cancer Therapeutics
Figure 75. Precision Cancer Therapeutics Industrial Chain
Figure 76. Methodology
Figure 77. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
